There are currently no products specifically developed to treat PMDD. Patients are most often prescribed anti-depressants (SSRI’s) or oral contraceptives (OC) for symptom relief. These treatments only gives symptom relief in some PMDD patients and are often associated with unacceptable side effects, including e.g. increased risk of thrombosis with some OCs. Asarina Pharma intends to develop Sepranolone as a unique first-in-class opportunity to address the need for improved treatments for PMDD.